Form 483

Duke Clinical Research Institute Form 483, 2015-11-04

FDA issued a Form 483 to Duke Clinical Research Institute on 2015-11-04 with 2 public-safe observations.

483· Form 483 issuedHuman Drugs2 observations

Duke Clinical Research Institute · Durham, United States · Issued November 4, 2015

Overview

  • 2 public-safe observations are available for this inspection.
  • 1 structured CFR citation is represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

4 Nov 2015
21 CFR 312.50

Ensuring compliance with plan and protocol

Cited by Betsy C Galliher, Tracy R Ball

4 Nov 2015
21 CFR 312.50

General responsibilities of sponsors

Cited by Betsy C Galliher, Tracy R Ball

Inspected site

DCDuke Clinical Research InstituteDurham, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 312.50Cited across public-safe Form 483 observations2x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 2 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere